journal article·2018

Therapy for cartilage defects: functional ectopic cartilage constructed by cartilage-simulating collagen, chondroitin sulfate and hyaluronic acid (CCH) hybrid hydrogel with allogeneic chondrocytes

Xianfang Jiang, Junting Liu, Qin Liu, Zhenhui Lu, Li Zheng, Jinmin Zhao, Xingdong Zhang

Biomaterials Science· Volume 6· Issue 6
Publisher page

Abstract

Objective To regenerate functional cartilage-mimicking ectopic cartilage as a source for the restoration of cartilage defects, we used a previously synthesized three-phase collagen, chondroitin sulfate and hyaluronic acid (CCH) hydrogel for the encapsulation of allogeneic chondrocytes with a diffusion chamber system that was buried subcutaneously in the host for 4 weeks and then implanted into a cartilage defect. Methods The CCH hydrogel was prepared and seeded with allogeneic chondrocytes from new-born rabbits, prior to being enveloped in a diffusion chamber that prevents cell ingrowth and vascular invasion of the host, as described previously. A collagen hydrogel (C) was used as the control. The diffusion chamber was embedded subcutaneously in an adult rabbit. 4 weeks later, the regenerated tissue was harvested from the diffusion chamber and then further used for cartilage repair in the same host. To evaluate the regenerated tissue, cell viability assay using calcein-acetoxymethyl (calcein-AM)/propidium iodide (PI) staining, biochemical analysis by examination of total DNA and GAG content, gene expression detection using RT-PCR for Col 1a1, Col 2a1, Acan, and Sox9, biomechanical detection and histological evaluation were implemented. Results Analysis of the cell activity and biochemical evaluation in vitro showed that cell proliferation, GAG secretion and gene/protein expression of cartilage specific markers were much higher in the CCH group than those in the C group. The CCH constructed ectopic cartilage tissue in vivo showed the typical characteristics of hyaline cartilage with higher expression of cartilage matrix markers compared with the C groups, as evidenced by morphological and histological findings as well as RT-PCR analysis. Furthermore, ectopic cartilage from CCH successfully facilitated the cartilage restoration, with higher morphological and histological scores and greater mechanical strength than that from C. Conclusion The three-phase CCH hydrogel, which is closer to natural cartilage matrix and is stiffer than collagen, may replace collagen as the "gold standard" for cartilage tissue engineering. This study may provide a new insight for cartilage repair using ectopic cartilage reconstructed from functional materials and allogeneic cells.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Proteoglycans and glycosaminoglycans research · Periodontal Regeneration and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

The College of Stomatology of Guangxi Medical University

Nanning

P.R. China

Guangxi Engineering Center in Biomedical Material for Tissue and Organ Regeneration

The First Affiliated Hospital of Guangxi Medical University

Department of Orthopaedics Trauma and Hand Surgery

Guangxi Collaborative Innovation Center for Biomedicine

National Engineering Research Center for Biomaterials

Sichuan University

Chengdu

China

Funding

National Natural Science Foundation of China

References (45)

Show source-provided references
1. Bedi · J. Bone Jt. Surg., Am. Vol. · 2010 · 92 · 99410.2106/JBJS.I.00895 ↗
2. Ma · Trials · 2017 · 18 · 51910.1186/s13063-017-2251-6 ↗
3. Maehara · Inflammation Regener. · 2017 · 37 · 2210.1186/s41232-017-0053-6 ↗
4. Arzi · Acta Biomater. · 2015 · 23 · 7210.1016/j.actbio.2015.05.025 ↗
5. Zheng · Tissue Eng., Part A · 2009 · 15 · 214510.1089/ten.tea.2008.0268 ↗
6. Zheng · Exp. Ther. Med. · 2014 · 7 · 114710.3892/etm.2014.1583 ↗
7. Lee · Chem. Rev. · 2001 · 101 · 186910.1021/cr000108x ↗
8. Yamaoka · J. Biomed. Mater. Res., Part A · 2006 · 78 · 110.1002/jbm.a.30655 ↗
9. Maleski · Connect. Tissue Res. · 1996 · 34 · 7510.3109/03008209609028895 ↗
10. Pedron · Adv. Healthcare Mater. · 2017 · 6 · 110.1002/adhm.201700529 ↗
11. Lim · Biomaterials · 2013 · 34 · 500710.1016/j.biomaterials.2013.03.037 ↗
12. Kawamura · J. Orthop. Sci. · 2014 · 19 · 102810.1007/s00776-014-0643-y ↗
13. Hartwell · Acta Biomater. · 2011 · 7 · 306010.1016/j.actbio.2011.04.024 ↗
14. Deng · Acta Biomater. · 2010 · 6 · 18710.1016/j.actbio.2009.07.027 ↗
15. Novak · Acta Biomater. · 2015 · 11 · 27410.1016/j.actbio.2014.09.031 ↗
16. Tamaddon · J. Mater. Sci. Mater. Med. · 2013 · 24 · 115310.1007/s10856-013-4882-9 ↗
17. Stuart · Biopolymers · 2008 · 89 · 84110.1002/bip.21024 ↗
18. Tian · Colloids Surf., B · 2013 · 105 · 25910.1016/j.colsurfb.2013.01.005 ↗
19. Ling Zhang · Carbohydr. Polym. · 2010 · 84 · 11810.1016/j.carbpol.2010.11.009 ↗
20. Jiang · Tissue Eng., Part A · 2010 · 16 · 162110.1089/ten.tea.2009.0681 ↗
21. DuRaine · Biomech. Model. Mechanobiol. · 2015 · 14 · 7310.1007/s10237-014-0589-1 ↗
22. Salbach · Biomaterials · 2012 · 33 · 841810.1016/j.biomaterials.2012.08.028 ↗
23. Rai · Crit. Rev. Eukaryotic Gene Expression · 2011 · 21 · 110.1615/CritRevEukarGeneExpr.v21.i1.10 ↗
24. Kontturi · Drug Delivery Transl. Res. · 2014 · 4 · 14910.1007/s13346-013-0188-1 ↗
25. Ingavle · J. Mater. Sci. Mater. Med. · 2012 · 23 · 15710.1007/s10856-011-4499-9 ↗
26. Akmal · J. Bone Jt. Surg., Br. Vol. · 2005 · 87 · 114310.1302/0301-620X.87B8.15083 ↗
27. Lim · Acta Biomater. · 2011 · 7 · 98610.1016/j.actbio.2010.10.009 ↗
28. Barreto · Acta Ortop. Bras. · 2015 · 23 · 9010.1590/1413-785220152302144341 ↗
29. Grishko · J. Biol. Chem. · 2009 · 284 · 913210.1074/jbc.M804178200 ↗
30. van Susante · Biomaterials · 2001 · 22 · 235910.1016/S0142-9612(00)00423-3 ↗
31. Lee · Biomacromolecules · 2006 · 7 · 220010.1021/bm060451x ↗
32. Amann · Acta Biomater. · 2017 · 52 · 13010.1016/j.actbio.2017.01.064 ↗
33. Onodera · FEBS Open Bio · 2015 · 5 · 47610.1016/j.fob.2015.05.007 ↗
34. Henry · J. Bone Miner. Res. · 2012 · 27 · 251110.1002/jbmr.1696 ↗
35. Kawakami · Curr. Opin. Cell Biol. · 2006 · 18 · 72310.1016/j.ceb.2006.10.007 ↗
36. Oh · PLoS One · 2010 · 5 · e1011310.1371/journal.pone.0010113 ↗
37. Lu · Tissue Eng., Part A · 2010 · 16 · 8110.1089/ten.tea.2009.0222 ↗
38. Callahan · Biomacromolecules · 2012 · 13 · 162510.1021/bm3003336 ↗
39. Garg · Biomaterials · 1989 · 10 · 41310.1016/0142-9612(89)90133-6 ↗
40. Stuart · Biomacromolecules · 2009 · 10 · 2510.1021/bm800888u ↗
41. Zheng · J. Appl. Biomater. Funct. Mater. · 2014 · 12 · 41
42. Zheng · J. Biomed. Mater. Res., Part A · 2010 · 93 · 78310.1002/jbm.a.32588 ↗
43. Moskalewski · Microsc. Res. Tech. · 2002 · 58 · 310.1002/jemt.10110 ↗
44. Weinand · Arch. Orthop. Trauma Surg. · 2006 · 126 · 59910.1007/s00402-005-0100-7 ↗
45. Revell · Tissue Eng., Part B · 2009 · 15 · 110.1089/ten.teb.2008.0189 ↗